ReviewThe Journal of infection2017
Is chickenpox so bad, what do we know about immunity to varicella zoster virus, and what does it tell us about the future?
Review in The Journal of infection, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 59 citations in OpenAlex.
- Seroprevalence of IgG Antibodies to Measles, Mumps, Rubella and Varicella in Adolescents with Documented Two-Dose MMR Vaccination: Cross-Sectional Study.Antibodies (Basel, Switzerland) · 2026Article
- Epidemiological characteristics and incidence prediction of varicella from 2014 to 2023 in Chongqing, China.Frontiers in public health · 2026Article
- Spatial-temporal patterns, seasonality, and age-specific trends of varicella in Hangzhou, China, 2019-2024.Frontiers in public health · 2026Article
- Analysis and comparison of chickenpox outbreaks in two schools at different educational stages: a mixed retrospective observational study.BMC infectious diseases · 2025Observational
- Article
- Epidemiological characteristics of breakthrough varicella cases among students in Jiulongpo District, Chongqing: implications for vaccination strategies.Frontiers in immunology · 2025Article
- Analysis of antibody dynamics in Chinese children aged 1-3 years after single-dose varicella vaccination: A 42 months prospective study.Human vaccines & immunotherapeutics · 2024Article
- Expanded spectrum of varicella disease and the need for vaccination in India.Human vaccines & immunotherapeutics · 2024Article
- Analysis on the epidemiological characteristics of varicella and breakthrough case from 2014 to 2022 in Qingyang City.Human vaccines & immunotherapeutics · 2023Article
- Maternal varicella antibodies in children aged less than one year: Assessment of antibody decay.PloS one · 2023Article
- Effectiveness of varicella vaccination during an outbreak in a large one-dose-vaccinated population in Shanghai.Human vaccines & immunotherapeutics · 2022Article
- A Dynamic Compartmental Model to Explore the Optimal Strategy of Varicella Vaccination: An Epidemiological Study in Jiangsu Province, China.Tropical medicine and infectious disease · 2022Article
- Comparison of varicella outbreaks in schools in China during different vaccination periods.Human vaccines & immunotherapeutics · 2022Article
- Varicella outbreaks in schools and kindergartens in Shanghai, China from 2011 to 2020.PloS one · 2022Article
- Modified vaccinia Ankara expressing EEHV1A glycoprotein B elicits humoral and cell-mediated immune responses in mice.PloS one · 2022Article
- The comparison of seroconversion rates among different varicella vaccines administered Turkish children; MAV/06 and vOka.Human vaccines & immunotherapeutics · 2021Article
- On recovery: re-directing the concept by differentiation of its meanings.Medicine, health care, and philosophy · 2021Article
- Correlates of COVID-19 Vaccine Hesitancy among a Community Sample of African Americans Living in the Southern United States.Vaccines · 2021Article
- SARS-CoV-2 Liability: The Hidden Mystery Behind Its Presentation in Children.Advances in experimental medicine and biology · 2021Review
- Cranial nerve involvement in varicella zoster virus after renal transplantation.Proceedings (Baylor University. Medical Center) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
Abstract
Varicella and zoster continue to cause significant morbidity and even mortality in children and adults. Complications include bacterial superinfection, central nervous system manifestations such as meningitis, encephalitis, and cerebellar ataxia, and pain syndromes especially post herpetic neuralgia. Many developed countries but not all, are now administering live attenuated varicella vaccine routinely, with a decrease in the incidence of disease, providing personal and herd immunity. There is some controversy, however, in some countries concerning whether a decrease in the circulation of wild type virus will result in loss of immunity to VZV in persons who have already had varicella. This manuscript reviews the complications of varicella and zoster in detail, the reasons for development of vaccines against these diseases, complications of vaccinations, and mechanisms by which immunity to this virus develops and is maintained. There are strong indications that the best way to control disease and spread of this virus is by vaccination against both.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.